{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:53:54Z","timestamp":1790805234779,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR 22-CE17-0031"],"award-info":[{"award-number":["ANR 22-CE17-0031"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Glycogen storage disease type III (GSDIII) is a rare genetic disease caused by mutations in the <jats:italic>AGL<\/jats:italic> gene encoding the glycogen debranching enzyme (GDE). The deficiency of this enzyme, involved in cytosolic glycogen degradation, leads to pathological glycogen accumulation in liver, skeletal muscles and heart. Although the disease manifests with hypoglycemia and liver metabolism impairment, the progressive myopathy is the major disease burden in adult GSDIII patients, without any curative treatment currently available.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Here, we combined the self-renewal and differentiation capabilities of human induced pluripotent stem cells (hiPSCs) with cutting edge CRISPR\/Cas9 gene editing technology to establish a stable <jats:italic>AGL<\/jats:italic> knockout cell line and to explore glycogen metabolism in GSDIII.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Following skeletal muscle cells differentiation of the edited and control hiPSC lines, our study reports that the insertion of a frameshift mutation in <jats:italic>AGL<\/jats:italic> gene results in the loss of GDE expression and persistent glycogen accumulation under glucose starvation conditions. Phenotypically, we demonstrated that the edited skeletal muscle cells faithfully recapitulate the phenotype of differentiated skeletal muscle cells of hiPSCs derived from a GSDIII patient. We also demonstrated that treatment with recombinant AAV vectors expressing the human GDE cleared the accumulated glycogen.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> This study describes the first skeletal muscle cell model of GSDIII derived from hiPSCs and establishes a platform to study the mechanisms that contribute to muscle impairments in GSDIII and to assess the therapeutic potential of pharmacological inducers of glycogen degradation or gene therapy approaches.<\/jats:p>","DOI":"10.3389\/fcell.2023.1163427","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:04:29Z","timestamp":1683875069000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Pathological modeling of glycogen storage disease type III with CRISPR\/Cas9 edited human pluripotent stem cells"],"prefix":"10.3389","volume":"11","author":[{"given":"Lucille","family":"Rossiaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fragner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Gardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Benabides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Pellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Cosette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"El Kassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Giraud-Triboult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/biomedicines10061428","article-title":"Skeletal muscle cells derived from induced pluripotent stem cells: A platform for limb girdle muscular dystrophies","volume":"10","author":"Bruge","year":"2022","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.5966\/sctm.2015-0224","article-title":"A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles","volume":"5","author":"Caron","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.omtm.2018.12.011","article-title":"Preclinical development of an AAV8-hUGT1A1 vector for the treatment of crigler-najjar syndrome","volume":"12","author":"Collaud","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1007\/s10545-009-1088-x","article-title":"Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet","volume":"32","author":"Dagli","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"B6","volume-title":"Glycogen storage disease type III","author":"Dagli","year":"1993"},{"key":"B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","article-title":"Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?","volume":"46","author":"Demo","year":"2007","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e001893","DOI":"10.1161\/CIRCGEN.117.001893","article-title":"Ion Channel dysfunctions in dilated cardiomyopathy in limb-girdle muscular dystrophy","volume":"11","author":"El-Battrawy","year":"2018","journal-title":"Circ. Genom Precis. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.actbio.2019.05.016","article-title":"Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications","volume":"92","author":"Goldfracht","year":"2019","journal-title":"Acta Biomater."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70341","DOI":"10.7554\/eLife.70341","article-title":"iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling","volume":"11","author":"Guo","year":"2022","journal-title":"Elife"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jcsm.12835","article-title":"Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells-derived innervated muscle fibres","volume":"13","author":"Laberthonni\u00e8re","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","article-title":"Hepatocellular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature","volume":"24","author":"Labrune","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-019-0815-2","article-title":"Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment","volume":"7","author":"Lafor\u00eat","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.omtm.2020.05.034","article-title":"A novel gene therapy approach for GSD III using an AAV vector encoding a bacterial glycogen debranching enzyme","volume":"18","author":"Lim","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e152970","DOI":"10.1172\/jci.insight.152970","article-title":"Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice","volume":"7","author":"Lim","year":"2022","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ymgme.2014.02.005","article-title":"Mouse model of glycogen storage disease type III","volume":"111","author":"Liu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.scr.2021.102333","article-title":"Patient-specific iPSC-derived cellular models of LGMDR1","volume":"53","author":"Mateos-Aierdi","year":"2021","journal-title":"Stem Cell Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"5","author":"Matsushita","year":"1998","journal-title":"Gene Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-014-0196-3","article-title":"Glycogen storage disease type III: Modified Atkins diet improves myopathy","volume":"9","author":"Mayorandan","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/hmg\/ddab218","article-title":"CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis","volume":"31","author":"M\u00e9rien","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cells11030537","article-title":"Evidence of adult features and functions of hepatocytes differentiated from human induced pluripotent stem cells and self-organized as organoids","volume":"11","author":"Messina","year":"2022","journal-title":"Cells"},{"key":"B25","volume-title":"Treatment of glycogen storage disease III","author":"Mingozzi","year":"2018"},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jcsm.12665","article-title":"Myogenesis modelled by human pluripotent stem cells: A multi-omic study of duchenne myopathy early onset","volume":"12","author":"Mournetas","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000509335","article-title":"Beneficial effects of modified Atkins diet in glycogen storage disease type IIIa","volume":"76","author":"Olgac","year":"2020","journal-title":"Ann. Nutr. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.3390\/ijms232213964","article-title":"Generation of the first human in vitro model for McArdle disease based on iPSC technology","volume":"23","author":"Ortu\u00f1o-Costela","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.bbadis.2014.07.029","article-title":"Glycogen storage disease type III: A novel agl knockout mouse model","volume":"1842","author":"Pagliarani","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/hum.2019.255","article-title":"Dose-escalation study of systemically delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx mouse model of duchenne muscular dystrophy","volume":"32","author":"Potter","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.ymthe.2018.04.023","article-title":"Inhibition of glycogen synthase II with RNAi prevents liver injury in mouse models of glycogen storage diseases","volume":"26","author":"Pursell","year":"2018","journal-title":"Mol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41467-017-02636-4","article-title":"Engineering human pluripotent stem cells into a functional skeletal muscle tissue","volume":"9","author":"Rao","year":"2018","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J. Med. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: Diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/jcsm.13094","article-title":"Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy","volume":"13","author":"Shahriyari","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B38","doi-asserted-by":"publisher","first-page":"12831","DOI":"10.1038\/srep12831","article-title":"Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells","volume":"5","author":"Shoji","year":"2015","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1242\/dmm.022277","article-title":"Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia","volume":"9","author":"Si-Tayeb","year":"2016","journal-title":"Dis. Model Mech."},{"key":"B40","doi-asserted-by":"publisher","first-page":"20417314221122127","DOI":"10.1177\/20417314221122127","article-title":"High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing","volume":"13","author":"Smith","year":"2022","journal-title":"J. Tissue Eng."},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2012.12.002","article-title":"Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III","volume":"108","author":"Sun","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e61540","DOI":"10.1371\/journal.pone.0061540","article-title":"Efficient and reproducible myogenic differentiation from human iPS cells: Prospects for modeling miyoshi myopathy in vitro","volume":"8","author":"Tanaka","year":"2013","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"140ra89","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1203\/PDR.0b013e318232154f","article-title":"Successful treatment of severe cardiomyopathy in glycogen storage disease type III with D,L-3-hydroxybutyrate, ketogenic and high-protein diet","volume":"70","author":"Valayannopoulos","year":"2011","journal-title":"Pediatr. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ymthe.2017.12.019","article-title":"Rescue of GSDIII phenotype with gene transfer requires liver- and muscle-targeted GDE expression","volume":"26","author":"Vidal","year":"2018","journal-title":"Mol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.2019.264","article-title":"High-throughput in vitro, ex vivo, and in vivo screen of adeno-associated virus vectors based on physical and functional transduction","volume":"31","author":"Westhaus","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.scr.2017.08.020","article-title":"Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi)","volume":"24","author":"Wu","year":"2017","journal-title":"Stem Cell Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00109-014-1127-4","article-title":"Correction of glycogen storage disease type III with rapamycin in a canine model","volume":"92","author":"Yi","year":"2014","journal-title":"J. Mol. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1242\/dmm.009712","article-title":"Characterization of a canine model of glycogen storage disease type IIIa","volume":"5","author":"Yi","year":"2012","journal-title":"Dis. Model Mech."},{"key":"B53","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-017-14063-y","article-title":"A skeletal muscle model of infantile-onset pompe disease with patient-specific iPS cells","volume":"7","author":"Yoshida","year":"2017","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.109.868885","article-title":"Cardiomyocyte differentiation of human induced pluripotent stem cells","volume":"120","author":"Zwi","year":"2009","journal-title":"Circulation"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1163427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:04:33Z","timestamp":1683875073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1163427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":55,"alternative-id":["10.3389\/fcell.2023.1163427"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1163427","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"article-number":"1163427"}}